HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks
There are 1 comment on the HIV and Hepatitis story from Nov 27, 2012, titled HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks. In it, HIV and Hepatitis reports that:The Stribild single-tablet-regimen -- formerly dubbed the Quad -- demonstrated "robust and durable" efficacy and continued to be well-tolerated through 96 weeks, according to findings from 2 studies presented at the 11th International Congress on Drug Therapy in HIV Infection this month in Glasgow.
Join the discussion below, or Read more at HIV and Hepatitis.
#1 Jan 15, 2013
Learn more about the HIV/AIDS drug Atripla at http://www.rxwiki.com/atripla
Add your comments below
|Gov't report: Efforts to reduce US uninsured st...||Jul 13||Repeal obama care||23|
|Insurance Co.'a are middle men||Jun 30||kneejerk52||1|
|Walgreens and LabCorp Collaborate to Bring Pati...||Jun 28||wagnous||1|
|Appalachian congressmen ask FDA to reclassify O... (May '07)||Jun 27||Ron Paul Liberty||37|
|Wanted Nashville suspect surrenders||Jun 24||baaarrrtt||2|
|This mother is looking for the lost necklace th...||Jun 22||Phyllis Schlafly ...||2|
|CDC panel again advises against FluMist||Jun '17||VACCINES MAIM KILL||1|
Find what you want!
Search Healthcare Industry Forum Now
Copyright © 2017 Topix LLC